Dementia: Is it time for a change in focus?

Alzheimer's and Dementia

Volumn 4, Issue 1 SUPPL. 1, 2008, Pages

  Kuller, Lewis H ^a   Lopez, Oscar L ^b  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Hypertension; Lipoproteins; MRI

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; ANTIINFLAMMATORY AGENT; ANTILIPEMIC AGENT; ANTINEOPLASTIC AGENT; APOLIPOPROTEIN E4; LIPOPROTEIN; LIPOPROTEIN RECEPTOR; TAU PROTEIN; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

AGING; ALZHEIMER DISEASE; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COGNITION; CORRELATION ANALYSIS; DEMENTIA; DIETARY INTAKE; DRUG EFFICACY; EDITORIAL; GENETIC SUSCEPTIBILITY; HUMAN; IN VIVO STUDY; LEWY BODY; LIPOPROTEIN METABOLISM; LONGITUDINAL STUDY; MEDICAL RESEARCH; METHODOLOGY; NEUROFIBRILLARY TANGLE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RISK FACTOR; SENILE PLAQUE; SOCIAL WORK;

ALZHEIMER DISEASE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PRIMARY PREVENTION; RISK FACTORS;

EID: 38049011353     PISSN: 15525260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jalz.2007.09.004     Document Type: Editorial

References (50)

1. Alzheimer's disease facts and figures 2007 (2007), Alzheimer's Association, Chicago
2. Jedrziewski M.K., Lee V.M.-Y., and Troganowski J.Q. Lowering the risk of Alzheimer's disease: evidence-based practices emerge from new research. Alzheimer's & Dementia 1 (2005) 152-160
3. Forman M.S., Trojanowski J.Q., and Lee V.M.-Y. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat Med 10 (2004) 1055-1063
4. Weiner M.W. Commentary on "Diagnosis of Alzheimer's disease: two decades of progress": central role of technology in the treatment and prevention of Alzheimer's disease. Alzheimer's & Dementia 1 (2005) 112-113
5. In: Keys A. (Ed). Coronary heart disease in seven countries (1970), American Heart Association, New York (Monograph 29)
6. Goldstein J.L., and Brown M.S. The LDL receptor defect in familial hypercholesterolemia: implications for pathogenesis and therapy. Med Clin North Am 66 (1982) 335-362
7. Lee J.H., Cheng R., Schupf N., Manly J., Lantigua R., Stern Y., et al. The association between genetic variants in SORL1 and Alzheimer disease in an urban, multiethnic, community-based cohort. Arch Neurol 64 (2007) 501-506
8. Rubinsztein D.C. The genetics of Alzheimer's disease. Prog Neurobiol 52 (1997) 447-454
9. Mattson M.P. Gene-diet interactions in brain aging and neurodegenerative disorders. Ann Intern Med 139 (2003) 441-444
10. Martins I.J., Hone E., Foster J.K., Sünram-Lea S.I., Gnjec A., Fuller S.J., et al. Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease. Mol Psychiatry 11 (2006) 721-736
11. Rubinsztein E.D.C. The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 443 (2006) 780-786
12. Goldberg A.L. Protein degradation and protection against misfolded or damaged proteins. Nature 426 (2003) 895-899
13. Anstey K.J., and Smith G.A. Interrelationships among biological markers of aging, health, activity, acculturation, and cognitive performance in late adulthood. Psychol Aging 14 (1999) 605-618
14. Colcombe S.J., Kramer A.F., Erickson K.I., Scalf P., McAuley E., Cohen N.J., et al. Cardiovascular fitness, cortical plasticity, and aging. Proc Natl Acad Sci 101 (2004) 3316-3321
15. Brayne C. The elephant in the room-healthy brains in later life, epidemiology and public health. Nat Rev 8 (2007) 233-239
16. Ferri C.P., Prince M., Brayne C., Brodaty H., Fratiglioni L., Ganguli M., et al. Global prevalence of dementia: a Delphi consensus study. Lancet 366 (2005) 2112-2117
17. Chandra V., Ganguli M., Pandav R., Johnston J., Belle S., and DeKosky S.T. Prevalence of Alzheimer's disease and other dementias in rural India: the Indo-US study. Neurology 51 (1998) 1000-1008
18. Hendrie H.C., Osuntokun B.O., Hall K.S., Ogunniyi A.O., Hui S.L., Unverzagt F.W., et al. Prevalence Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans. Am J Psychiatry 152 (1995) 1485-1492
19. Kramer A.F., Colcombe S.J., McAuley E., Scalf P.E., and Erickson K.I. Fitness, aging and neurocognitive function. Neurobiol Aging 26 (2005) S124-S127
20. Frank R.A., Galasko D., Hampel H., Hardy J., de Leon M.J., Mehta P.D., et al. Biological markers for therapeutic trials in Alzheimer's disease: proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease. Neurobiol Aging 24 (2003) 521-536
21. Bouwman F.H., van der Flier W.M., Schoonenboom N.S.M., van Elk E.J., Kok F., Rijmen F., et al. Longitudinal changes of CSF biomarkers in memory clinic patients. Neurology 69 (2007) 1006-1011
22. Hill D.L. Multi-site MRI studies: problems and principles. (abstract #IM-05). Alzheimer's & Dementia 3 (2007) S93
23. Teipel S.J., Born C., and Hampel H. Advantages of MRI. (abstract #IM-09). Alzheimer's & Dementia 3 (2007) S93
24. DeKosky S.T., Mathis C.A., Price J.C., Ikonomovic M.D., Hamilton R.L., Abrahamson E.E., et al. Correlation of regional in vivo Pittsburgh compound B (PIB) retention with in vitro PIB, AB levels, and amyloid plaque density: validation of PIB-PET in postmortem human brain. (abstract #P-029). Alzheimer's & Dementia 3 (2007) S105
25. Brown T.R., Habeck C., Borogovac A., and Scarmeas N. Spatial patterns in CBF depression in Alzheimer's disease from multivariate analysis of continuous arterial spin labeling MRI. (abstract #P-021). Alzheimer's & Dementia 3 (2007) S102
26. Chen K., Reiman E.M., Alexander G.E., Smilovici O., Lee W., Reschke C., et al. The pattern and severity of FDG PET abnormalities in Alzheimer's disease and amnestic mild cognitive impairment: preliminary findings from the Alzheimer's disease neuroimaging imitative. (abstract #P-024). Alzheimer's & Dementia 3 (2007) S102
27. Kuller L.H., Arnold A.M., Longstreth Jr. W.T., Manolio T.A., O'Leary D.H., Burke G.L., et al. White matter grade and ventricular volume on brain MRI as markers of longevity in the Cardiovascular Health Study. Neurobiol Aging 28 (2007) 1307-1315
28. van Oijen M., de Maat M.P.M., Kardys I., de Jong F.J., Hofman A., Koudstaal P.J., et al. Polymorphisms and haplotypes in the C-reactive protein gene and risk of dementia (NBA-6589). Neurobiol Aging 28 (2007) 1361-1366
29. Willcox B.J., He Q., Chen R., Yano K., Masaki K.H., Grove J.S., et al. Midlife risk factors and healthy survival in men. JAMA 296 (2006) 2343-2350
30. Depp C.A., and Jeste D.V. Definitions and predictors of successful aging: a comprehensive review of larger quantitative studies. Am J Geriatr Psychiatry 14 (2006) 6-20
31. Lantz P.M., House J.S., Lepkowski J.M., Williams D.R., Mero R.P., and Chen J. Socioeconomic factors, health behaviors, and mortality: results from a nationally representative prospective study of US adults. JAMA 279 (1998) 1703-1708
32. Atzmon G., Rincon M., Rabizadeh P., and Barzilai N. Biological evidence for inheritance of exceptional longevity. Mech Ageing Dev 126 (2005) 341-345
33. Schneider J.A., Arvanitakis Z., Bang W., and Bennett D.A. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology (2007) June 13 [Epub ahead of print]
34. Gorelick P.B., and William M. Feinberg Lecture: cognitive vitality and the role of stroke and cardiovascular disease risk factors. Stroke 36 (2005) 875-879
35. Nash D.T. Nutritional and exercise aspects of cognitive impairment. J Clin Lipidol 1 (2007) 242-247
36. Anstey K.J., von Sanden C., Salim A., and O'Kearney R. Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am J Epidemiol 166 (2007) 367-378
37. Rovio S., Käreholt I., Helkala E.-L., Viitanen M., Winblad B., Toumilehto J., et al. Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease. Lancet Neurol 4 (2005) 705-711
38. Verghese J., Lipton R.B., Katz M.J., Hall C.B., Derby C.A., Kuslansky G., et al. Leisure activities and the risk of dementia in the elderly. N Engl J Med 348 (2003) 2508-2516
39. Saczynski J.S., Pfeifer L.A., Masaki K., Korf E.S.C., Laurin D., White L., et al. The effect of social engagement on incident dementia: the Honolulu-Asia Aging Study. Am J Epidemiol 163 (2006) 433-440
40. Fratiglioni L., Paillard-Borg S., and Winblad B. An active and socially integrated lifestyle in late life might protect against dementia. Lancet Neurol 3 (2004) 343-353
41. Godin O., Dufouil C., Ritchie K., Dartigues J.-F., Tzourio C., Pérès K., et al. Depressive symptoms, major depressive episode and cognition in the elderly: the Three-City Study. Neuroepidemiology 28 (2007) 101-108
42. Kuller L.H. Statins and dementia. Curr Atheroscler Rep 9 (2007) 154-161
43. Scarmeas N., Luchsinger J.A., Mayeux R., and Stern Y. Mediterranean diet and Alzheimer disease mortality. Neurology 69 (2007) 1084-1093
44. Schaefer E.J., Bongard V., Beiser A.S., Lamon-Fava S., Robins S.J., Au R., et al. Plasma phosphatidylcholine docasahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch Neurol 63 (2006) 1545-1550
45. Kuller L.H. Commentary on "Vascular cognitive impairment: today and tomorrow". Alzheimer's & Dementia 2 (2006) 195-197
46. Schmidt R., Petrovic K., Ropele S., Enzinger C., and Fazekas F. Progression of leukoaraiosis and cognition. Stroke 38 (2007) 2619-2625
47. Kuller L.H., and Lopez O.L. Treatment of hypertension and prevention of dementia. Alzheimer's & Dementia 1 (2005) 38-40
48. Executive Committee of Vas-Cog on behalf of the General Assembly. Declaration of San Antonio, Texas. Neuroepidemiology 28 (2007) 191-192
49. Sagare A., Deane R., Bell R.D., Johnson B., Hamm K., Pendu R., et al. Clearance of amyloid-β circulating lipoprotein receptors. Nat Med 13 (2007) 1029-1031
50. Thal L., Kuller L., Bowman K., Breitner J., Evans D., Farrer L., et al. The Nevada Vital Aging Initiative: a private-public partnership to study early predictors of dementia. Alzheimer's & Dementia 3 (2007) 62-67